While the Apple Watch can display glucose readings from connected Continuous Glucose Monitors (CGMs), it's crucial to understand that the watch itself does not measure blood sugar levels. Apple has not received FDA clearance for any wrist-based glucose monitoring technology. This distinction is vital, as the watch currently serves as a display interface, not an independent diagnostic tool.
The pursuit of noninvasive glucose monitoring is a significant undertaking, fraught with clinical and technical challenges. Leading CGM manufacturers like Dexcom and Abbott offer FDA-cleared devices that provide direct measurements. However, these require separate sensors. The FDA has cautioned consumers against smartwatches claiming glucose monitoring capabilities without approval, citing potential risks from inaccurate readings. Apple's research in biosensing continues, but a functional, noninvasive glucose sensor for the Apple Watch remains in the developmental stages, awaiting rigorous validation and regulatory clearance.
